D. Ignatova

Discipline

Sociologie (1) Psychologie (1) Anthropologie biologique (1)

Type de document

Articles (6)

Co-auteur

Date

Source

Mot-clé

Patients (4) Patients (4) Expression (3) protéine (2) Treatment (2) Lymphomas (2) Cells (2) Cell death (2) Agent (Philosophy) (2) roman (2) thérapie (1) peau (1) mutation (1) gestion (1) lumière (1) anticorps (1) analyse (1) évaluation (1) maladie (1) cancer (1) Blockades (1) Cancer (1) Inhibitors (1) Diseases (1) Sheds (1) Phenotype (1) Transgenic mice (1) Neovascularization (1) Therapeutics (1) Theater (1)

Documents écrit par D. Ignatova (6) | parle de D. Ignatova (0)

Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors.
M. Bobrowicz et al.
A novel proangiogenic B cell subset is increased in cancer and chronic inflammation.
W. van de Veen et al.
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.
I. Saulite et al. (2020)
ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions.
AH Willrodt et al.
Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn
R Higgins et al. (2019)
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma.
D Kollmann et al.